
FDA & Government News


June 17, 2025
Aldeyra Therapeutics Resubmits Reproxalap NDA for the Treatment of DED
Ophthalmology Management



Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.




Advertisement
Recommendations
Advertisement